Annual CFF
$1.31 M
+$234.90 K+21.81%
31 December 2022
Summary:
Serina Therapeutics annual cash flow from financing activities is currently $1.31 million, with the most recent change of +$234.90 thousand (+21.81%) on 31 December 2022. During the last 3 years, it has risen by +$234.90 thousand (+21.81%). SER annual CFF is now at all-time high.SER Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$86.00 K
-$5.28 M-98.40%
30 September 2024
Summary:
Serina Therapeutics quarterly cash flow from financing activities is currently $86.00 thousand, with the most recent change of -$5.28 million (-98.40%) on 30 September 2024. Over the past year, it has increased by +$84.00 thousand (+4200.00%). SER quarterly CFF is now -99.15% below its all-time high of $10.09 million, reached on 31 March 2023.SER Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$8.18 M
+$84.00 K+1.04%
30 September 2024
Summary:
Serina Therapeutics TTM cash flow from financing activities is currently $8.18 million, with the most recent change of +$84.00 thousand (+1.04%) on 30 September 2024. Over the past year, it has dropped by -$1.91 million (-18.93%). SER TTM CFF is now -18.93% below its all-time high of $10.09 million, reached on 30 September 2023.SER TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SER Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +4200.0% | -18.9% |
| 3 y3 years | +21.8% | - | - |
| 5 y5 years | - | - | - |
SER Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +21.8% | -99.2% | +4200.0% | -18.9% | +199.7% |
| 5 y | 5 years | at high | +21.8% | -99.2% | +4200.0% | -18.9% | +199.7% |
| alltime | all time | at high | +21.8% | -99.2% | +4200.0% | -18.9% | +199.7% |
Serina Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $86.00 K(-98.4%) | $8.18 M(+1.0%) |
| June 2024 | - | $5.37 M(+96.7%) | $8.10 M(+196.6%) |
| Mar 2024 | - | $2.73 M(>+9900.0%) | $2.73 M(-72.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $2000.00(-100.0%) | $10.09 M(+0.0%) |
| Mar 2023 | - | $10.09 M | $10.09 M |
| Dec 2022 | $1.31 M(+21.8%) | - | - |
| Dec 2021 | $1.08 M | - | - |
FAQ
- What is Serina Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Serina Therapeutics?
- What is Serina Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Serina Therapeutics?
- What is Serina Therapeutics quarterly CFF year-on-year change?
- What is Serina Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Serina Therapeutics?
- What is Serina Therapeutics TTM CFF year-on-year change?
What is Serina Therapeutics annual cash flow from financing activities?
The current annual CFF of SER is $1.31 M
What is the all time high annual CFF for Serina Therapeutics?
Serina Therapeutics all-time high annual cash flow from financing activities is $1.31 M
What is Serina Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of SER is $86.00 K
What is the all time high quarterly CFF for Serina Therapeutics?
Serina Therapeutics all-time high quarterly cash flow from financing activities is $10.09 M
What is Serina Therapeutics quarterly CFF year-on-year change?
Over the past year, SER quarterly cash flow from financing activities has changed by +$84.00 K (+4200.00%)
What is Serina Therapeutics TTM cash flow from financing activities?
The current TTM CFF of SER is $8.18 M
What is the all time high TTM CFF for Serina Therapeutics?
Serina Therapeutics all-time high TTM cash flow from financing activities is $10.09 M
What is Serina Therapeutics TTM CFF year-on-year change?
Over the past year, SER TTM cash flow from financing activities has changed by -$1.91 M (-18.93%)